Tag: Delays

Categories
World News

Home delays vote on infrastructure, funds plans

House delays vote on infrastructure, budget plans

House Speaker Nancy Pelosi (D-CA) takes questions as she holds her weekly news conference with Capitol Hill reporters at the Capitol in Washington, July 22, 2021.

Elizabeth Frantz | Reuters

The House scrapped a planned Monday vote to advance two key economic proposals as centrist Democrats and party leaders failed to break a stalemate over how to proceed with President Joe Biden’s sprawling economic agenda.

House Speaker Nancy Pelosi has pushed to pass a $1 trillion bipartisan infrastructure bill and her party’s separate $3.5 trillion spending plan at the same time. The process could take months, as the House needs to join the Senate in passing a budget resolution before lawmakers write a final proposal.

Nine members of Pelosi’s caucus urged the California Democrat to approve the Senate-passed infrastructure legislation this week and send it to Biden’s desk. Pelosi wants to pair the bills to ensure the centrists wary of a $3.5 trillion price tag and progressives who consider the infrastructure plan inadequate back both measures.

CNBC Politics

Read more of CNBC’s politics coverage:

Democratic leaders have a tiny margin for error as they try to pass their plan to expand the social safety net without a Republican vote. They will need to win over all 50 members of their Senate caucus and all but three Democrats in the House.

In a letter over the weekend, Pelosi told Democrats she aims to pass both the infrastructure bill and Democrats’ spending plan before Oct. 1.

This story is developing. Please check back for updates.

Subscribe to CNBC on YouTube.

Categories
Health

Apple delays return to workplace till January as Covid instances surge

Apple delays return to office until January as Covid cases surge

This photo, taken in March 2019, shows Apple’s headquarters in Cupertino, California.

felixmizioznikov | iStock editorial team | Getty Images

Apple employees won’t be returning to the office until January amid fears of rising coronavirus cases, CNBC has confirmed.

News of the delay was first reported by Bloomberg.

The company has told employees that it will continue to monitor the coronavirus situation and give them at least a month’s notice before they have to go back to the office. The delay applies to all of the company’s employees worldwide.

Apple offices and stores will remain open.

The number of Covid cases in the USA is increasing. According to CNBC analysis of the data compiled by Johns Hopkins University, Florida, Louisiana, Hawaii, Oregon and Mississippi all hit new highs in their seven-day average of new cases on Sunday.

Apple isn’t the only big tech company putting its office return plans on hold. Last week, Facebook said it would postpone its plan to bring U.S. employees back to the office until January 2022 due to concerns about the Covid-19 Delta variant.

Meanwhile, Amazon announced a similar plan for corporate employees earlier this month.

Apple had already postponed the planned return of the office to October after it had initially announced that it would send employees three days a week from September.

Some large US companies are also bringing back mask requirements for workers regardless of their vaccination status, amid concerns about an increase in Covid-19 infections.

Categories
World News

Boeing additional delays Starliner OFT-2 crew spacecraft take a look at flight

Boeing further delays Starliner OFT-2 crew spacecraft test flight

Boeing’s Starliner capsule sits on the launch pad prior to the launch of the OFT-2 mission on an Atlas V rocket.

United Launch Alliance

Boeing’s second unmanned flight test of its Starliner spacecraft has been delayed by at least two months due to problems with the capsule’s drive valves, the company said on Friday.

The latest mission – called Orbital Flight Test 2 or OFT-2 – was previously targeted for December 2020, but Boeing delayed the launch several times, with August 3 being the most recent target. During preparations on launch day, Boeing discovered that 13 valves on the spacecraft’s propulsion system were not opening, causing the company to delay launch.

While the company’s engineers restored functionality to nine of the 13 valves over the past week and a half, Boeing Vice President John Vollmer said the team had “exhausted all possible options” to fix Starliner while the capsule was on the rocket – which required a return to the company’s processing facility for further investigation.

According to Vollmer, Boeing is working with Aerojet Rocketdyne, the manufacturer of the valves, to identify the exact cause of the problems and analyze possible preventive measures or new designs.

The extra work means Boeing won’t have an opportunity to launch OFT-2 this month, NASA Commercial Crew program manager Steve Stich told reporters, and is “definitely on the other hand” delaying an agency mission scheduled for mid-October.

The OFT-2 delay announcement comes about 19 months after Boeing’s first flight test went wrong.

OFT-2 represents a repetition of Boeing’s first unmanned flight test in December 2019. This first Starliner mission was canceled when, after a successful launch, the spacecraft’s flight control system misfired and the capsule did not reach the International Space Station as planned. While Boeing was able to test many parts of the Starliner during the shortened flight, NASA declared the flight test a “tight call” and said the spacecraft could have been lost twice during the mission.

The company made dozens of changes, along with NASA, according to an investigation. In addition, Boeing is assuming the cost of OFT-2 after allocating $ 410 million shortly after the initial flight test. Vollmer said Friday he wasn’t sure how much the delay and extra work will cost Boeing.

Competing with SpaceX

Boeing developed Starliner as part of NASA’s Commercial Crew program, which the space agency began in 2010 when the space shuttle retired. The aim of the program was to encourage private sector companies to develop the most cost-effective, innovative and safest way to get astronauts to and from the International Space Station.

The program was structured as a multi-stage competition in which companies competed for NASA contracts to build space transportation systems under certain parameters set by the agency. NASA eventually awarded the contracts to SpaceX and Boeing, with the latter aerospace entrepreneur receiving nearly $ 5 billion to develop the Starliner.

Built to carry up to five people to the International Space Station, Starliner launches on an Atlas V rocket – built and operated by United Launch Alliance, a joint venture between Boeing and Lockheed Martin.

SpaceX and Boeing have been building and testing their crew transport systems for almost a decade. However, SpaceX’s successful launch of astronauts in May 2020 was an important milestone for the company as Boeing had to catch up. SpaceX’s launch marked the first time NASA astronauts took off from US soil since 2011 and the first time a commercially built spacecraft carried NASA astronauts.

Since then, SpaceX has flown two astronaut missions for NASA with its Crew Dragon capsules and safely transported a total of 10 people into space. Elon Musk’s company has two more crew launches planned for this fall, with the private Inspiration4 mission and the Crew 3 mission for NASA.

Become a smarter investor with CNBC Pro.
Get stock picks, analyst calls, exclusive interviews and access to CNBC TV.
Sign in to get started Try it for free today.

Categories
Health

Novartis CEO says Covid-related physician go to delays seemingly impacting most cancers analysis charges

Novartis CEO says Covid-related doctor visit delays likely impacting cancer diagnosis rates

The health-care system is still seeing lower rates of diagnoses for certain conditions after the coronavirus pandemic kept non-Covid patients away from the hospital early on, Novartis CEO Vasant Narasimhan told CNBC on Wednesday.

“I think the signals that were sent that ultimately asked patients to stay away from the emergency room, stay away from hospitals, sent a very powerful message to patients not to get the care that they needed,” Narasimhan said on “Closing Bell.” “It may have been appropriate given the public health emergency, but over time what that does is it creates a significant need for better treatments for these patients.”

Narasimhan, who joined Novartis in 2005, said that while trends are positive, lower rates of diagnoses in areas such as cardiovascular disease and oncology remain. For the latter, he said diagnoses are still 30% to 40% lower than pre-Covid-19 levels. Novartis makes cancer treatments.

Nearly 1 in 3 Americans between the ages of 50 and 80 delayed an in-person medical visit last year due to worries about exposure to Covid, according to a poll from the National Poll on Healthy Aging based at the University of Michigan Institute for Healthcare Policy and Innovation. The poll, taken in January, found that 24% of people with cancer and 30% of people with heart conditions had delayed at least one in-person visit.

“Cancer patients that are diagnosed later tend to have worse outcomes, similarly for cardiovascular disease patients that don’t get the therapies that they need,” Narasimhan said. “That in turn creates more burden on the health-care systems over time.”

As Covid cases increase in the U.S. and around the world due to the highly transmissible delta variant, Narasimhan hopes lessons from the early stages of the health crisis have been learned. “I think it’s critical now, this time around, we ensure patients can maintain their care even as the pandemic ebbs and flows over the coming months,” he said.

“We remain optimistic that even as we go through various waves of Covid that the health-care systems have learned that we need to maintain care for noncommunicable diseases, other chronic diseases,” he added.” “Otherwise in effect we create another epidemic, a syndemic so to speak, of these other diseases.”

On Wednesday, Novartis beat analyst expectations for second-quarter revenue and earnings. Narasimhan said the Swiss drugmaker witnessed a resurgence in demand across many therapeutic areas, and noted the company had 9% growth in sales and 13% growth in operating income. 

Novartis is currently involved in manufacturing the Pfizer-BioNTech Covid vaccines, and is assisting CureVac in making vaccines, as well. Novartis also produces monoclonal antibodies to treat Covid for partner companies,” Narasimhan said. “We’re doing a lot, but also ready to do more if needed.”

Categories
Politics

E.U. Delays Digital Levy as Tax Talks Proceed

E.U. Delays Digital Levy as Tax Talks Proceed

Other finance ministers indicated that the delay was another sign of progress.

“It’s very, very good that we are now going to the next step, discussing how we will implement this at the European Union and that the European Union is deciding not to go with its own proposal to the public today,” Olaf Scholz, Germany’s finance minister, said as he entered the meeting.

The E.U. digital levy proposal faced a difficult path to becoming law in Europe, but the prospect of a new proposal that could be construed as a tax that targets American companies would have been another distraction for the fragile negotiations.

The United States has already been angered by other digital taxes that countries like France, Italy and Britain have enacted, which are separate from the new proposal. More than a dozen countries have enacted or announced plans in recent years to move forward with their own digital taxes.

The Biden administration has asked countries to immediately drop their digital taxes and has prepared retaliatory tariffs on a wide swath of European goods, including cheese, wine and clothing. As part of the global tax negotiations, countries have said they are willing to do so in exchange for additional tax on the largest and most profitable multinational enterprises, those with profit margins of at least 10 percent, that would be based on where their goods or services were sold, even if they had no physical presence there.

France, Europe’s biggest proponent of a digital tax, had no comment Monday. Its finance minister, Bruno Le Maire, had said during the weekend that France would legally commit to withdrawing its digital services tax only after an agreement was in effect, which is unlikely to happen before 2023.

In remarks at the meeting on Monday, Ms. Yellen emphasized the importance of a close relationship between the United States and the European Union and underscored the importance of the global tax agreement that she has been helping to broker. She argued that a deal over a global minimum tax would help European nations make important investments in their economies and reduce inequality.

“Long-run fiscal sustainability is critically important, which is one of the reasons why we need to continue working collectively to implement a global minimum tax of at least 15 percent, in line with the commitment the G20 made just days ago,” Ms. Yellen said. “We hope all E.U. member states will join the consensus and the European Union will move forward on this issue at E.U. level.”

Categories
Politics

Republican Dissent Delays Passage of China Competitiveness Invoice

Republican Dissent Delays Passage of China Competitiveness Bill

An expansive $ 195 billion bill, aimed at strengthening the nation’s competitive advantage over China, hit a hook in the Senate Friday after a small group of Republicans objected to the swift pass and slated for next month the bipartisan legislation had voted.

New York Democrat Senator Chuck Schumer, who had urged the move to be approved before the Senate left for its weeklong Memorial Day hiatus, abruptly changed course on Friday, saying he would take the opposition from Republicans Completion will complete the measure in early June. The bill, which Mr. Schumer co-drafted with Indiana Republican Senator Todd Young, is expected to be largely passed with the support of both parties.

Legislation had moved rapidly through the Senate, fueled by growing fears among members of both parties that the United States was losing its economic and technological edge over China. The last-minute delay, however, followed nearly 24 hours of legislative disorder, beginning with an intense round of closed circuit haggling in which the Senators made substantial changes to the sprawling bill, and ended with a midnight broadcast of complaints from a small group of Conservative Senators those who complained had not had time to check the contents.

Wisconsin Senator Ron Johnson, along with a small group of Republicans, tarnished the legislative process with an objection late Thursday night, preventing the Democrats from moving the bill forward. Speaking from the Senate early Friday morning, he complained that the Senators had not been given enough time to review the legislation and that none of his preferred priorities – particularly one to fund a wall on the southern border – had been included be.

Other Republicans, who followed suit, argued that the bill – which would also allocate $ 52 billion to a previously created program to subsidize the semiconductor industry – was just too expensive.

“We have been fiscally irresponsible, frankly, and every opportunity we have now to bring this to the attention of the American people must be seized,” said Senator Cynthia Lummis, Republican of Wyoming. “There are concepts in this bill that I find compelling, but it’s now over $ 200 billion.”

Their grievances reflected greater dissatisfaction within their party, and Republican senators expressed anger at how quickly the measure had gone through the chamber. But the goal of the legislation – to compete with China – as well as a variety of parish items added to the bill to increase support, won over a large number of Conservatives, many of whom resented their peers’ antics keeping them had in Washington.

Republican support underscored a wider shift in the party that had followed Donald J. Trump’s leadership. More Conservatives backed federal interventions to shore up American manufacturing, citing an increasing threat from China.

Categories
Health

Covid-19 Vaccines: Novavax Stories Extra Delays

Covid-19 Vaccines: Novavax Reports More Delays

Novavax, one of the earliest players in the world’s vaccination race against Covid, delivered disheartening news Monday, saying its highly protective vaccine would not be approved in the US or UK until July and would not reach peak production by the end of the year.

The delays announced during a profit call with investors are the most recent setback for the little-known Maryland company that received up to $ 1.6 billion from the federal government last year and its product is in clinical trials has shown robust results. Despite these achievements, the company has struggled to show it can deliver on its promise to bring 2 billion doses to the world this year. Novavax has never launched a vaccine in its 34-year history.

Speaking on the conference call, the company’s President and Chief Executive Officer Stanley C. Erck said the regulatory and manufacturing hurdles causing the delay have now been resolved. “Almost all of the major challenges have been overcome and we can clearly see the light at the end of the tunnel,” he said.

Investors didn’t seem to agree: by Tuesday morning, the company’s stock had fallen to $ 133.86, down nearly 17 percent, although it rebounded a little later in the day.

“I don’t see much good for them right now,” said Rob Smith, general manager of Capital Alpha Partners, an investment research firm.

The company’s delay is unlikely to affect wealthy countries like the US, which are being flushed with vaccines from Moderna, Pfizer-BioNTech, and Johnson & Johnson.

It’s likely that this will have a significant impact on the rest of the world, however, as Novavax only signed a deal with Gavi, a public-private global vaccine partnership, last week to sell 1.1 billion doses of its shot at low and medium levels – to deliver. Income Countries. Novavax has other contracts with countries such as South Korea, Japan and Australia and has agreements with eight manufacturing facilities around the world.

In January, the company estimated it would reach its full production capacity of 150 million cans per month by the middle of this year. This forecast was later revised after a lack of supplies such as filters and the huge disposable bags used in vaccine production. On Monday, the company delayed its estimate again, anticipating production of 100 million cans per month by the end of the third quarter and production of 150 million cans per month by the fourth quarter.

One of its key manufacturing partners, the Serum Institute in India, has faced its own manufacturing and geopolitical challenges. A fire at the facility earlier this year reduced capacity, and in April Adar Poonawalla, director of Serum, urged the United States to restrict access to raw vaccine ingredients. And although Novavax’s contract with serum aims to serve the rest of the world through its agreement with Gavi, the Indian government has banned the export of vaccines from the country as it grapples with a deadly second wave of Covid-19.

“Serum is the backbone of global vaccine supplies,” said Andrea Taylor, associate director of the Duke Global Health Innovation Center, which pursues global vaccine businesses. “I think for countries in South and Southeast Asia in particular, as well as for countries in Africa, it is difficult to overestimate the impact this will have.”

Novavax has also thrown back regulatory hurdles. On Monday, company executives said a problem now resolved with an “assay” – a test that was required to confirm that their product could be consistently manufactured on a commercial scale at multiple factories – was gaining regulatory approvals around the world Delayed countries like the UK and the United States would not give approval until July. The company’s employees once said they were hoping to get approval for their vaccine in April.

The delay is particularly noticeable in the UK, where Novavax reported positive results from its clinical trial in January.

British officials convinced Novavax to set up a study there last year, partly because they promised rapid clinical development and regulatory approval. But time is running out: around two-thirds of UK adults have received an initial dose of a coronavirus vaccine, largely made by AstraZeneca, and each adult is expected to be offered one by the end of July.

Updated

May 11, 2021 at 4:32 p.m. ET

The role of the vaccine in the UK depends in part on how quickly Novavax can start distributing its vaccine. A UK factory that makes the vaccines has announced that they will be ready by the summer. The country recently turned away from AstraZeneca intake in younger people because of the risk of very rare blood clots, so Novavax may be an alternative for people under 40.

The country is also investigating the effects of giving a second dose of the Novavax vaccine to people who have already received a first dose of Pfizer or AstraZeneca.

In the US, the Novavax setback sheds new light on the massive deal with the US government. As recently as 2019, the company was on the verge of closing after another vaccine made a major trial and had to sell its manufacturing facility to raise money.

Last year, the Trump administration placed a big bet on the tiny company as part of its Operation Warp Speed ​​project, signing a $ 1.6 billion contract earlier this year to supply 110 million cans. In April, the total amount of the deal increased to $ 1.75 billion, according to Novavax. The company’s major study in the United States and Mexico is still ongoing, despite executives on Monday that they expected the results of that study “in a few weeks.”

Novavax officials said they now didn’t expect to deliver these doses by the end of this year or early 2022. A Novavax spokeswoman said there was no penalty for later delivery in her contract with the U.S. government.

Novavax’s spotty track record offers no confidence in the challenge of producing billions of cans, said Les Funtleyder, healthcare portfolio manager at E Squared Capital Management, which invests in domestic and emerging markets. “It seems they really weren’t prepared for a challenge of this magnitude,” he said.

Recent news about internal sales – such as the departure of Novavax’s chief financial officer last month, five months after he took office for personal reasons – doesn’t help, Funtleyder said. “It’s a bad look,” he said.

But even if there’s a challenging path to follow as a straggler, Novavax’s vaccine could fill important loopholes, some experts said. In the United States, it could be used as a booster shot to bolster dwindling immunity, or the Biden government could choose to donate the vaccine to other countries in need, as it does with the unused supply of AstraZeneca doses .

Novavax has announced that it will develop a new version of its vaccine to address the variant circulating in South Africa. And it was recently announced that it would be investigating the shot in children over the age of 12 to catch up with Moderna and Pfizer, who have already tested their products in that age group.

The vaccine can also be stored at normal refrigeration temperatures without the freezing temperatures required for Pfizer and Moderna vaccines.

“By the end of 2021, there will still be a great need for safe, effective vaccines that can travel well,” said Ms. Taylor of Duke University. “Novavax seems to fit that description.”

Dr. Saad B. Omer, director of the Yale Institute for Global Health, noted that countries with multiple vaccines available were able to switch to other options when concerns about Johnson & Johnson and AstraZeneca vaccines were raised due to blood clot association.

“It’s good to hedge our bets,” he said. “For example, if we want to avoid one body blow after another in low-income countries in many parts of the world that affects everyone, we have to vaccinate a large part of the world.”

Benjamin Mueller and Noah Weiland contributed to the reporting.

Categories
Business

Retailers pay extra to fly bikes to scorching tubs from China as backup at U.S. ports delays deliveries

Retailers pay more to fly bikes to hot tubs from China as backup at U.S. ports delays deliveries

Containers are seen on a shipping dock as the global coronavirus disease (COVID-19) outbreak continues in the port of Los Angeles, California on April 16, 2020.

Lucy Nicholson | Reuters

A ship with 197 containers of peloton bikes and goods circled at anchor off the port of Los Angeles just before Christmas and entered a hold pattern on December 22nd until it was allowed to dock on January 2nd, according to global shipping data company MarineTraffic.

“The ship and Peloton’s expected delivery time lost 12 days while their product was almost swimming distance from shore,” said Import Genius trade data analyst William George. “This is a crazy example of the problem Peloton and other US importers are facing.”

The combination of record container volumes in the port of Los Angeles – the most heavily frequented container port in the western hemisphere due to its proximity to Asia – and delays caused by Covid-19 is slowing down imports into the USA, according to the International Longshore and Warehouse Union. Around 800 of the 15,000 members were due to Covid-19 unemployed – they either recovered from the virus or otherwise quarantined at home.

Record congestion in ports around the world has led some companies to abandon ocean shipping for air freight in order to get popular or seasonal items to shelves faster. This not only saves valuable time, but also money. According to Freightos, the international online freight market, airfares are still more expensive than shipping via ocean freight, but they have been falling in recent months.

400% more

“While air freight was volatile in the first few months of Covid, rising 400% between February and April 2020, ocean freight has become a bottleneck in global supply chains, making air freight a more profitable option in some cases.” “stated Eytan Buchman, CMO of Freightos.

Some of the congestion in U.S. ports is expected to decrease as more longshore workers are vaccinated against the coronavirus, which began Feb. 12. Only 5% of longshore workers have had vaccinations to date, said Gene Seroka, general manager of the Port of Los Angeles. He said the port is advocating “all levels of government” to vaccinate longshore workers to reduce congestion in the ports.

CH Robinson air freight

Source: CH Robinson

Peloton, who refused to comment on the article, referred CNBC to the company’s quarterly letter to shareholders published last month. The company said its profit margins for the last three months of the year were squeezed by additional shipping costs of $ 100 million during the critical holiday season.

“The global increase in shipping traffic has resulted in significant delays in all types of goods arriving in US ports, including Peloton products,” said Josh Foley, CEO of Peloton, in a February 4 letter to members. “These unpredictable delays have resulted in painful delivery dates for many people as Peloton bikes, treads and accessories have been kept in port for more than five times longer than usual.”

The Peloton shipment is just one example of the variety of goods held up in US ports.

Waiting for dock

According to MarineTraffic, 30 container ships were anchored in the ports of Los Angeles and Long Beach on Monday. More than 30 container ships are expected to arrive at the port of LA and more than 27 are expected to dock in the port of Long Beach in late March. Among the anchored ships waiting to be unloaded in the port of Los Angeles is the APL Charleston, which carried the late peloton deliveries in January. It arrived back loaded with Chinese exports on February 18.

The delays in December weren’t unusual, said Captain Adil Ashiq, MarineTraffic’s chief executive officer for the U.S. West Region.

CH Robinson air freight

Source: CH Robinson

“It is a reality that many ships, supply chain and logistics service providers are currently facing in the Port of Los Angeles and the Port of Long Beach,” he said in an interview. Port congestion data shows that the average time a container ship was anchored outside the dock last week was just over 7.5 days before it could travel inland, Ashiq said. “Now that the APL Charleston is at anchor again, it may face similar circumstances as it did on its previous port visit in December, but of course this is a cruise so anything can happen.”

The bottleneck in the ports has increased the cost of shipping, making air freight, which is usually considerably more expensive, looks like a relative bargain – especially considering the time savings. Airship prices have fallen dramatically in recent months.

A 250-kilogram air freight with a full container from China to the US has fallen in price from about 60% of the cost of a full container to only about 36%, he said.

“In other words, for the right kind of cargo, and certainly the right value, air is becoming a more compelling option, both with capacity and with far shorter transit times,” said Eytan Buchman, CMO of the international online freight market, Freightos.

Hot tubs and bikes

Brian Bourke, chief growth officer at Seko Logistics, said the time savings in product arrival justify the cost to their customers who have to meet consumer demand.

“If you’re looking to ship a hot tub across the ocean from Shanghai to New York, shipping a lighter hot tub will cost around $ 1,000, but it takes at least 35 to 45 days,” he said in an interview. That doesn’t include an extra 7-14 days if you have to book in advance, he said. Shipping air freight costs anywhere from $ 2,000 to $ 3,000, depending on its weight.

“But you only need three to four days to get your hot tub,” he said. “So if you pay two or three times, you save four to seven weeks now. In the end, the math makes sense for certain senders right now.”

Kim Peterson, transportation manager for Canyon Bicycles USA, said they ship most of their inventor by water, but their most popular bikes are being shipped via air to meet growing demand.

“Air is faster and we have to meet customer demand,” he said. “I could pay an additional $ 1,000 to $ 2,000 to get my product in an (ocean) container at the head of the line in China, but that doesn’t matter because the cargo is in LA’s congestion . “

60 to 75 days

Before the pandemic, shipping took 20 to 30 days, he said. Now it’s about 60 to 75 days while air freight takes three to five days, Peterson said. “It’s a big difference. We are currently behind in Asia,” he said. “We can’t wait. That would have an impact on sales.”

Shawn Richard, vice president of global air freight in New York at Seko Logistics, tells CNBC that they don’t expect the peak load to end anytime soon.

“We regularly fly 65-inch TVs from China to the US,” said Richard. “We saw air freight up 40% in December. Large items like hot tubs were also transported. Our ocean freight teams are now selling air freight.”

Richard says that large recreational items like ping pong tables and exercise equipment like treadmills are usually shipped by sea because of the cost. Now they are moving by air due to an increase in demand. In the Covid-19 pandemic, people are locked inside but are looking for ways to stay fit and entertaining outside.

“Barbecues and related merchandise like lawn / patio furniture, inflatable pools, filtering devices, and anything that could be used to improve safety at home instead of family vacations are now moving by air,” he said.

The lack of reliability in retail has pushed the functionality of the logistics and supply chains to their limits. John Foley, CEO of Peloton, recently told CNBC that the company would be spending an additional $ 100 million on expediting shipping to reduce delivery delays.

“We are seeing the industries in need of accelerated shipping being blown against the rush and waiting by the sea,” said Matt Castle, vice president, air cargo products and services, CH Robinson. Recreational vehicles and parts that used to be shipped by sea have shifted to air freight, he said. “One of the things I never thought air would move is vacuum cleaners. It’s a hot topic now with so many people at home.”

Seasonal deliveries

Castle said the drive to the air is a combination of factors: companies with a narrow seasonal window to sell products and production-based industries looking to re-establish a rhythm and catch up on inventory.

“Ocean congestion is increasing to meet orders and drive demand for air freight,” said Castle.

Stephen Svajian, CEO and co-founder of Anova Culinary, which sells its precision combi ovens and cookers to COSCO, Target and Amazon, said they are increasing their air freight orders in response to increasing demand for the “home dining experience”. “

“We decide which products to air freight based on the set retail date and consumer expectations. We don’t want to be sold out or fulfill orders,” said Svajian. “This year there is more pressure to use air due to delays at sea.”

This logistical strategy of getting some products in the air isn’t unique to the US. Castle said they are also seeing companies in Europe making the switch. “This market is very strong. There is a lack of container capacity everywhere.”

Ag exported

Air is also becoming an option for US exporters struggling to get their products overseas as carriers refuse US Ag exports to return empty containers. They make far fewer shipping exports from the US to China – $ 744 per container versus $ 4,922 for Chinese exports to the US. The time and money saved when empty containers do not have to be loaded, unloaded and cleaned offsets the lost money on the way back to Asia.

It also costs US farmers who are struggling to ship their goods overseas. Their access to international markets “is being severely undermined by the unprecedented dysfunction and cost of maritime transportation services,” said Peter Friedman, executive director of the Agriculture Transportation Coalition.

Richard of Seko Logistics said spices and perishable goods like lobster were shipped to China by air back in October.

There doesn’t seem to be a quick fix to unblock US ports, leaving companies like Canyon with few options.

“In the cycling world, when the sun comes out, people want to ride bikes,” said Peterson of Canyon. “Demand is still high. It’s pretty obvious that we need to keep going and ventilate.”

Categories
Business

Virgin Galactic (SPCE) falls after check delays push again tourism service

Virgin Galactic (SPCE) falls after test delays push back tourism service

Preflight operations are ongoing on the Unity SpaceShipTwo vehicle and the company’s mother ship Eve.

Virgo Galactic

Virgin Galactic shares fell in trading on Friday after the company’s fourth quarter results showed delays in its flight test program. The expected start of its commercial service has now been postponed to 2022.

The space tourism company reported a quarterly loss that was in line with Wall Street analysts’ expectations, but the next space flight test of its SpaceShipTwo vehicle “Unity” has been postponed from February to May. The company identified an electromagnetic interference problem with Unity on a new flight control computer. CEO Michael Colglazier said the company anticipates eight to nine weeks of proofreading.

Delays in Virgin Galactic’s spacecraft testing program, which had previously been thrown back after an engine stall during a space flight attempt in December, caused the company to postpone its schedule for starting regular space tourism flights.

Virgin Galactic’s shares fell 11.9% on Friday, trading at $ 37.23 per share. The share has risen significantly since the beginning of the year and has gained more than 55% since the beginning of the year, even after the decline on Friday.

The new plan for 2021

Colglazier gave investors an updated look at the milestones Virgin Galactic is expected to achieve this year given the testing delays.

The company’s next big event won’t be Unity, but rather the launch of the second spacecraft in the Virgin Galactic fleet – and the first of its SpaceShip III generation. According to Colglazier, the SpaceShip III vehicle has a “modular design” with “improved manufacturing and assembly processes” that the company expects to enable “better performance in terms of flight rate” and maintenance.

In the meantime, Virgin Galactic will be working this spring to address the electromagnetic interference (EMI) issue with Unity. The company’s analysis found that EMI was the main culprit behind the flight abandonment in December, and additional EMI issues during pre-flight preparations resulted in Virgin Galactic withdrawing from a space test expected earlier this month.

“To reduce EMI levels, we will add functionality to the new flight control computer. Once we have completed these changes, we will thoroughly test the system on site in both the lab and Unity and then begin our flight test program again,” said Virgin Galactic President Mike Moses on the company’s earnings conference call.

Unity’s flight attempt in May will effectively be a replica of the December test with only two pilots on board.

Meanwhile, Virgin Galactic expects the first SpaceShip III vehicle “to begin gliding tests this summer,” Colglazier said. In addition, the company will begin assembling a second SpaceShip III vehicle.

“Our current flight test protocol for the first SpaceShipThree vehicle is four glide flights and four powered flights, and we expect the space flights to generate revenue,” said Colglazier.

A shadowy look at the company’s upcoming SpaceShip III generation.

Virgo Galactic

Given Unity’s past delays, Coglalzier declined to provide specific target dates for the second space flight attempt, saying only that Virgin Galactic expects it to happen “this summer”. Unity’s second space flight will carry four passengers along with the pilots – most of the people Virgin Galactic has flown at one time.

Then Virgin Galactic will conduct a third space flight test, in which Unity company founder Sir Richard Branson has been on the road for almost two decades.

The company added a fourth space flight test for Unity as part of a partnership with the Italian Air Force. Colglazier said the flight will carry three passengers and several research payloads that will serve as “suborbital astronaut training” for the Italians. That flight is expected to “take place in late summer or early fall,” said Colglazier, and will complete Unity’s flight tests.

Virgin Galactic then begins a period of maintenance outages that Colglazier expects to last about four months. The company will carry out an “analysis and rehabilitation phase” with its carrier aircraft Eve, Spacecraft Unity and SpaceShip III.

“We decided to implement improvements and accelerations of the long-term maintenance updates for our mother ship Eve to improve the predictability and frequency of the flight rate,” said Colglazier.

Given the downtime, Virgin Galactic now expects “Unity to begin flying private astronauts in early 2022” – marking the start of the company’s commercial space tourism service. The company most recently believes that “SpaceShip III will be able to complete its flight tests,” Colglazier said early next year.

Wall Street lowers expectations

Virgin Galactic pilots walk to the company’s SpaceShipTwo Unity spacecraft attached to the Eve jet carrier aircraft.

Virgo Galactic

Several analysts have adjusted expectations for Virgin Galactic’s future results, lowering prospects in light of the testing delays.

“The big news out of print was the redesign of the flight plan,” said UBS analyst Myles Walton in a statement to investors.

UBS has a neutral rating for Virgin Galactic and is lowering its price target from $ 52 per share to $ 40 per share. Walton said he saw “a bit more technical risk on the agenda than before” despite being “encouraged by the speed in building a base for economies of scale when the green light is given to commercial operations”.

Alembic Global Advisors downgraded Virgin Galactic from overweight to neutral, with the price target shifting from $ 27 per share to $ 39 per share.

“What drives our downgrade is a combination of the stock’s current valuation (the stock has risen 78% since more than doubling in 2020) and a fresh outlook from management, the additional investment and longer time it takes to achieve the Passenger travel by consumers who now appear to be on a timeline of early 2022, “Alembic analyst Pete Skibitski wrote in a note.

Credit Suisse analyst Robert Spingarn adjusted his company’s price target for Virgin Galactic from $ 36 to $ 42 per share at the start of the year in light of the company’s strong performance.

“The updated plan, based on higher numbers and newer versions of the spacecraft, is likely to take longer than what we considered when we started reporting,” Spingarn said.

Credit Suisse pushed back its forecast that Virgin Galactic would achieve a high volume of flights from Spaceport America in New Mexico by 2025 from 2024. Spingarn also noted that Virgin Galactic appears to be “happy” with about 11-quarters cash on their runway, according to current quarterly burn rate.

“We now have a higher line of investment which, depending on the pace of further progress and the burn rate, could require additional capital by the end of 2022,” noted Spingarn.

Subscribe to CNBC PRO for exclusive insights and analysis as well as live business day programs from around the world.

Categories
Health

Delays Flip Canada’s Covid Vaccination Optimism Into Nervousness

Delays Turn Canada’s Covid Vaccination Optimism Into Anxiety

OTTAWA – Canada seemed to be off to a quick start. Regulators had approved a coronavirus vaccine that Pfizer co-developed shortly before the United States, and national news broadcasts were soon filled with pictures of people receiving their first injections.

But hopes raised by the December vaccination launch – including news that Canada had ordered doses ten times its population – have worsened. Manufacturing issues at Pfizer and Moderna, makers of the two vaccines currently approved in Canada, have resulted in reduced shipments – including several weeks with no vaccine at all.

But while the disruption has become a talking point for the nation, more fundamental factors affecting Canada’s strategic decisions and manufacturing realities have always resulted in the launch of vaccinations being a test run rather than a full rollout.

Even if Canada is back on schedule, this nation is expected to receive just six million doses of 37.5 million people by the end of next month. So far, only about 1.5 million people have been injected.

Updates to a global vaccination ranking now get almost as much media coverage as hockey results. With the UK and even the United States continuing to climb the rankings despite their troubles, Canada has fallen significantly on the list that sits between Bangladesh and Romania this week.

The country’s vaccination fears have caused a drop in approval ratings for Prime Minister Justin Trudeau’s performance during the pandemic, according to polls. Almost 60 percent of Canadians believe the country should do better or at least as well as other developed nations, according to a survey.

It has also sometimes sparked fierce criticism from the conservative opposition in parliament and from several provincial premieres whose governments are responsible for putting needles in weapons.

“While the world is vaccinating millions of times, the government can only deliver a few thousand,” Conservative leader Erin O’Toole said in parliament on Tuesday. “Where’s the plan to get vaccines into the arms of Canadians?”

Mr. Trudeau acknowledged the impatience but tried to give assurances.

“People are worried, people are fed up with this pandemic,” he said at a press conference last week. “There is a lot of fear and there is a lot of noise right now. So I want to assure the Canadians that we are on the right track. “

Canada wasn’t alone. Short shipments of vaccines have also created tension in Europe and other parts of the world

The pressure on Mr. Trudeau could ease. After Pfizer slowed and temporarily suspended shipments to Canada while a factory in Belgium was rebuilt to increase production, Pfizer sent its largest vaccine shipment to Canada this week. However, part of this broadcast was delayed by storms en route across the United States.

While the prime minister said that Pfizer’s new shipments will allow Canada to hit its six million can target by the end of March, it still means the vast majority of Canadians will likely wait for their shots well into the summer becomes.

Vaccine and infection control specialists say Canada’s start has always been sluggish due to several key factors, most notably its decision last year to split its 414 million orders across seven different companies to reduce risk rather than upfront for a single vaccine put suppliers. To date, only two of these companies have approved vaccines for use in Canada.

Updated

Apr. 21, 2021, 6:38 p.m. ET

Canada also has inherent drawbacks: Most notably, its lack of an established vaccine manufacturer headquartered in the country and its relatively limited manufacturing capacity for making the vaccines developed by overseas companies.

Experts said the short or late deliveries shouldn’t have surprised anyone so far.

“There has never been a vaccine rollout that did not go into bottlenecks due to problems fixing manufacturing errors,” said Dr. Scott Halperin, Professor of Medicine at Dalhousie University in Halifax and Medical Director of the Canadian Center for Vaccination Science. “Anyone who didn’t anticipate hiccups in the manufacturing process just wasn’t aware of the past.”

Dr. David N. Fisman, professor of epidemiology at the University of Toronto’s Dalla Lana School of Public Health, attributed the national hand pressing to another factor.

“It looks more like we got what we expected with the occasional hiccup,” he said. “I think most of the sound and anger really just relates to the political scoring. Is there anything the federal government could realistically have done to get more vaccines earlier and magically stop those hiccups? “

Doug Ford, Ontario’s Conservative Prime Minister, suggested an answer despite his political viability. During a press conference last month, he called on President Biden to send Canada a million doses of vaccine from a Pfizer Michigan facility located within driving distance of the international border.

“Our American friends, help us,” said Mr Ford, who has avoided criticizing Mr Trudeau. “You have a new president, no more excuses.”

Under the Canadian system, the provinces are responsible for the operation of health systems, including administering vaccinations, while the federal government regulates vaccines and drugs and negotiates prices. With the pandemic, Mr. Trudeau also took responsibility for purchasing the country’s vaccine supply.

Brian Pallister, the Prime Minister of Manitoba, broke with that program last week, announcing that his province will be spending $ 36 million Canadian dollars to buy vaccines from a small business in Calgary, Alberta that is powered by the development of a vaccine for cancer has switched to the coronavirus.

“I just want a Canadian home advantage,” Pallister said as he urged other prime ministers to work with him to “work with him on a Canadian-made solution, not just for today but for tomorrow.”

However, the vaccine from Calgary Company, Providence Therapeutics, isn’t going to speed up vaccination rates anytime soon. The company, which has asked Mr Trudeau’s government for financial support, did not start the first phase of human trials of his vaccine until late January.

Assuming the vaccine is approved, Providence expects production to begin late this year or early next year – long after Mr Trudeau’s September goal of vaccinating all Canadians.

With Canada released little information about its vaccination contracts, Mahesh Nagarajan, a professor in the Sauder School of Business at the University of British Columbia in Vancouver, said it was impossible to see if anything could be done to expedite supplies.

Dr. However, Nagarajan said the country’s relatively small population and lack of membership in a trading bloc like the European Union put it in a comparatively weak negotiating position.

“When production is done elsewhere and resources are scarce, you can’t just assume that people will ship things,” said Dr. Nagarajan, adding that the province’s effectiveness in administering vaccines is likely to determine whether Mr Trudeau’s September target can be met.

Dr. Fisman said he was optimistic that Canada “will be inundated with vaccine supplies by the summer”. By then, he had some advice for Canadians.

“People need to take a few deep breaths and get through March and April,” he said. “I think we’re actually fine.”